Study to Assess the ART Impact on the Brain Outcomes. The ARBRE Study (ARBRE)
Observational Prospective Trial to Investigate the Impact of Antiretroviral Therapy Initiation With Integrase Strand Transfer Inhibitors on Brain Outcomes:The ARBRE Study:Impact of AntiRetroviral Therapy With INSTI on BRain outcomEs (ARBRE) According to the Time of Therapy Initation
Sponsor: BCN Checkpoint
A observational or N/A phase clinical study on Cognitive Impairment and HIV-1 Infection, this trial is completed. The trial is conducted by BCN Checkpoint and has accumulated 11 data snapshots since 2015. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
11 versions recorded-
Mar 2025 — Present [monthly]
Completed
-
Sep 2024 — Mar 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2024 — Jul 2024 [monthly]
Completed
-
Jan 2023 — Jan 2024 [monthly]
Completed
▶ Show 6 earlier versions
-
Dec 2022 — Jan 2023 [monthly]
Completed
-
Jan 2021 — Dec 2022 [monthly]
Completed
-
Jul 2020 — Jan 2021 [monthly]
Completed
-
Jun 2019 — Jul 2020 [monthly]
Completed
-
Apr 2019 — Jun 2019 [monthly]
Completed
-
Mar 2019 — Apr 2019 [monthly]
Completed
First recorded
Oct 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- BCN Checkpoint
- Consorci Sanitari de Terrassa
- Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
- Germans Trias i Pujol Hospital
- Institut d'Investigació Biomèdica de Bellvitge
- Institut de Diagnostic per la Imatge
- IrsiCaixa
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.